Are Parkinson disease patients protected from some but not all cancers?

Suppr

超能文献

作者信息

Strongosky Audrey J, Farrer Matthew, Wszolek Zbigniew K

出版信息

Neurology. 2008 Nov 11;71(20):1650; author reply 1650-1. doi: 10.1212/01.wnl.0000339367.54460.8c.

DOI:10.1212/01.wnl.0000339367.54460.8c

PMID:19001259

Abstract

摘要

相似文献

Are Parkinson disease patients protected from some but not all cancers?

Neurology. 2008 Nov 11;71(20):1650; author reply 1650-1. doi: 10.1212/01.wnl.0000339367.54460.8c.

Parkinson's disease and cancer: insights for pathogenesis from epidemiology .

Ann N Y Acad Sci. 2009 Feb;1155:324-34. doi: 10.1111/j.1749-6632.2008.03681.x.

On the use of clusters to determine environmental influence on disease.

Arch Neurol. 2005 Feb;62(2):331; author reply 331-2. doi: 10.1001/archneur.62.2.331-a.

APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.

J Geriatr Psychiatry Neurol. 2009 Sep;22(3):166-70. doi: 10.1177/0891988709332945. Epub 2009 Mar 25.

Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

Neurology. 2009 Mar 31;72(13):1121-6. doi: 10.1212/01.wnl.0000338632.00552.cb. Epub 2008 Nov 19.

Rhinorrhea and olfaction in Parkinson disease.

Neurology. 2008 Dec 2;71(23):1929; author reply 1929. doi: 10.1212/01.wnl.0000339402.09956.2b.

Central pain and Parkinson disease.

Arch Neurol. 2009 Feb;66(2):282-3; author reply 283. doi: 10.1001/archneurol.2008.545.

Factors contributing to the development of restless legs syndrome in patients with Parkinson disease.

Mov Disord. 2009 Mar 15;24(4):579-82. doi: 10.1002/mds.22410.

Haplotype analysis of the engrailed-2 gene in young-onset Parkinson's disease.

Neurodegener Dis. 2009;6(3):102-5. doi: 10.1159/000207796. Epub 2009 Mar 6.

[Molecular genetics and pathogenesis of Parkinson disease].

No Shinkei Geka. 2009 Jun;37(6):531-41.

引用本文的文献

LRRK2 inhibition potentiates PARP inhibitor cytotoxicity through inhibiting homologous recombination-mediated DNA double strand break repair.

Clin Transl Med. 2021 Mar;11(3):e341. doi: 10.1002/ctm2.341.

Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.

Mov Disord. 2019 Sep;34(9):1392-1398. doi: 10.1002/mds.27807. Epub 2019 Jul 26.

Cancer in Parkinson's disease.

Parkinsonism Relat Disord. 2016 Oct;31:28-33. doi: 10.1016/j.parkreldis.2016.06.014. Epub 2016 Jun 20.

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.

JAMA Neurol. 2015 Jan;72(1):58-65. doi: 10.1001/jamaneurol.2014.1973.

Cancer and neurodegeneration: between the devil and the deep blue sea.

PLoS Genet. 2010 Dec 23;6(12):e1001257. doi: 10.1371/journal.pgen.1001257.

LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease.

Mov Disord. 2010 Nov 15;25(15):2536-41. doi: 10.1002/mds.23314.

Statistical method on nonrandom clustering with application to somatic mutations in cancer.

BMC Bioinformatics. 2010 Jan 7;11:11. doi: 10.1186/1471-2105-11-11.

The particular relationship between Parkinson's disease and malignancy: a focus on skin cancers.

J Neural Transm (Vienna). 2009 Nov;116(11):1503-7. doi: 10.1007/s00702-009-0322-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验